Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2014 | |
| Sales | 365 |
| Operating Expenses | 5,397 |
| Operating Income | -5,032 |
| Interest Expense | 24 |
| Other Income | 136,109 |
| Pre-tax Income | 131,054 |
| Income Tax | 5,195 |
| Net Income Continuous | 125,859 |
| Net Income | $125,859 |
| EPS Basic Total Ops | 2.20 |
| EPS Basic Continuous Ops | 2.20 |
| EPS Diluted Total Ops | 2.20 |
| EPS Diluted Continuous Ops | 2.20 |
| EBITDA(a) | $131,162 |